Xenetic Biosciences, Inc.XBIONASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank77
3Y CAGR-28.1%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
-28.1%/yr
Quarterly compound
Percentile
P77
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 25.96% |
| Q2 2025 | 23.74% |
| Q1 2025 | 14.36% |
| Q4 2024 | -141.49% |
| Q3 2024 | 65.72% |
| Q2 2024 | -6.60% |
| Q1 2024 | -2.02% |
| Q4 2023 | -10.98% |
| Q3 2023 | -0.44% |
| Q2 2023 | -22.70% |
| Q1 2023 | 42.22% |
| Q4 2022 | -84.39% |
| Q3 2022 | 69.91% |
| Q2 2022 | -67.68% |
| Q1 2022 | 13.47% |
| Q4 2021 | -36.33% |
| Q3 2021 | -22.07% |
| Q2 2021 | 17.78% |
| Q1 2021 | -12.16% |
| Q4 2020 | 84.13% |
| Q3 2020 | -692.79% |
| Q2 2020 | 19.14% |
| Q1 2020 | -0.78% |
| Q4 2019 | 86.85% |
| Q3 2019 | -546.15% |
| Q2 2019 | -3.78% |
| Q1 2019 | 19.03% |
| Q4 2018 | 9.56% |
| Q3 2018 | 10.54% |
| Q2 2018 | -11.17% |
| Q1 2018 | -141.00% |
| Q4 2017 | 297.05% |
| Q3 2017 | 22.71% |
| Q2 2017 | -1.86% |
| Q1 2017 | -632.28% |
| Q4 2016 | 84.17% |
| Q3 2016 | 94.83% |
| Q2 2016 | -1237.52% |
| Q1 2016 | 1.54% |
| Q4 2015 | 31.86% |